Taselisib
Taselisib is an orally bioavailable inhibitor of the class I phosphatidylinositol 3-kinase (PI3K) alpha isoform (PIK3CA), with potential antineoplastic activity.
| Catalog Number | T1999 |
| Alternative Name(s) | RG-7604 , GDC-0032 |
| Research Area | Metabolism|||PI3K/Akt/mTOR signaling |
| Molecular Formula | C24H28N8O2 |
| CAS# | 1282512-48-4 |
| Purity | 99.46% |
| SMILES | CC(C)n1nc(C)nc1-c1cn2CCOc3cc(ccc3-c2n1)-c1cnn(c1)C(C)(C)C(N)=O |
| Size | 100 mg |
| Supplier Page | https://www.targetmol.com/compound/Taselisib |
| Additional Information | https://www.targetmol.com/datasheet/T1999 |